Management of Stevens-Johnson Syndrome with Systemic Symptoms
This patient requires immediate transfer to a burn center or ICU with SJS/TEN expertise, discontinuation of all suspected causative drugs, and initiation of comprehensive multidisciplinary supportive care. 1
Immediate Actions
Stop the Culprit Drug
The single most critical intervention is immediate discontinuation of the suspected causative medication. Fever, joint pain, and diarrhea in the context of SJS suggest systemic involvement and potential progression to toxic epidermal necrolysis (TEN). 1
Assess Severity and Transfer
- Calculate SCORTEN score immediately to predict mortality risk (ranges from 1% with 0 parameters to 99% with 7 parameters) 1
- Transfer without delay to a burn center or ICU experienced in SJS/TEN management if >10% body surface area (BSA) shows epidermal loss 1
- The presence of fever, joint pain, and diarrhea suggests significant systemic involvement requiring intensive monitoring
Hospital Setting and Initial Stabilization
Environmental Controls
- Barrier-nurse in a side room with controlled humidity
- Pressure-relieving mattress mandatory
- Ambient temperature raised to 25-28°C 1
Multidisciplinary Team Assembly
Immediately activate a team including:
- Dermatology and/or plastic surgery (core)
- Intensive care physicians
- Ophthalmology
- Specialist skincare nursing
- Additional consultants: gastroenterology (for diarrhea), oral medicine (for lip involvement), pain team, dietetics, microbiology, pharmacy 1
Specific Management of Presenting Symptoms
Lip and Oral Involvement
The lip swelling and involvement requires aggressive local care:
- Apply white soft paraffin ointment to lips immediately, then every 2 hours 1
- Use mucoprotectant mouthwash (e.g., Gelclair) three times daily to protect ulcerated surfaces
- Clean mouth daily with warm saline or oral sponge, gently sweeping labial and buccal sulci to prevent fibrotic scarring
- Anti-inflammatory oral rinse with benzydamine hydrochloride every 3 hours, especially before eating 1
Critical pitfall: Oral involvement often precludes normal eating and drinking. Institute nasogastric feeding with a silicone tube early if oral intake is compromised. 1
Fever Management
Important distinction: Fever in SJS/TEN may be disease-related OR indicate secondary sepsis—the most common cause of death. 1
Monitor carefully for signs of systemic infection beyond fever:
- Confusion
- Hypotension
- Reduced urine output
- Reduced oxygen saturation
- Increased skin pain
- Rising C-reactive protein and neutrophilia 1
Do NOT give prophylactic systemic antibiotics—this increases skin colonization, particularly with Candida. Only institute antimicrobial therapy if clinical signs of infection are present. 1
Joint Pain (Analgesia)
SJS/TEN is characterized by severe cutaneous pain requiring aggressive management. While the guidelines don't provide complete analgesia protocols in the excerpts provided, pain control is explicitly identified as a critical component requiring pain team involvement. 1
Diarrhea and Gastrointestinal Involvement
The presence of diarrhea suggests mucosal involvement beyond skin and lips. This has important implications:
- Prioritize enteral nutrition via nasogastric route to prevent peptic ulceration and limit bacterial translocation from the gut 1
- Gastroenterology consultation is specifically recommended for GI involvement 1
- Continuous enteral nutrition throughout acute phase: 20-25 kcal/kg daily during catabolic phase, increasing to 25-30 kcal/kg during recovery 1
Comprehensive Supportive Care
Fluid Resuscitation
Critical dosing: SJS/TEN requires LESS fluid than burn formulas predict. Use the formula: body weight × % BSA epidermal detachment (NOT the Parkland formula, which overestimates and causes pulmonary/cutaneous/intestinal edema). 1
Skin Management
- Minimize shearing forces when handling—antishear technique essential 1
- Regularly cleanse with warmed sterile water/saline or chlorhexidine (1:5000)
- Apply greasy emollient (50% white soft paraffin with 50% liquid paraffin) over entire epidermis, including denuded areas
- Apply topical antimicrobial only to sloughy areas (consider silver-containing products, but limit use if extensive areas involved due to absorption risk)
- Leave detached epidermis in situ as biological dressing; decompress blisters by piercing
- Apply nonadherent dressings (Mepitel or Telfa) to denuded dermis
- Use secondary foam/burn dressing to collect exudate (Exu-Dry) 1
Infection Surveillance
Denuded dermis becomes colonized sequentially:
- Initially: Staphylococcus aureus
- Later: Gram-negative rods (especially Pseudomonas aeruginosa) 1
Monitor for monoculture on swabs from multiple sites—indicates one organism becoming predominant and increases likelihood of invasive infection. 1
Systemic Therapy Considerations
While the 2016 UK guidelines focus primarily on supportive care, recent evidence (2025) suggests early initiation of systemic therapy is crucial to improve prognosis. 2 Options include glucocorticosteroids, intravenous immunoglobulin, cyclosporine, TNF-alpha inhibitors, or plasmapheresis, though high-quality comparative studies remain lacking. 3
Key Pitfalls to Avoid
- Delaying transfer: Any patient with >10% BSA involvement needs specialized center care immediately
- Overaggressive fluid resuscitation: Use the modified formula, not burn formulas
- Prophylactic antibiotics: Only treat documented infection
- Rough handling: Shearing forces worsen epidermal detachment
- Ignoring oral involvement: Early nasogastric feeding prevents nutritional compromise
- Missing sepsis: Fever alone doesn't distinguish disease from infection—look for other signs
Follow-Up Requirements
Long-term multidisciplinary follow-up during the first year is essential to monitor for cutaneous, mucosal, visual, and psychological sequelae. 2 Oral involvement specifically can lead to labial/intraoral scarring restricting mouth opening and sicca syndrome in up to 40% of patients. 1